Philip KovachSenior Scientist, Development Sciences at Avidity BiosciencesSpeaker
Profile
Philip Kovach is a Senior Scientist in Pharmacokinetics/Pharmacodynamics at Avidity Biosciences. He holds a Master of Science in Drug Development and Product Management from the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and has over 12 years of experience advancing antibody oligonucleotide conjugate (AOC) therapies from discovery through clinical development. His work spans bench science, bioanalytical strategy/execution for GLP and clinical studies, and contributions to clinical pharmacology analyses. Philip has supported del-zota (AOC 1044) for Duchenne muscular dystrophy since inception and is a contributing author on related publications and regulatory filings.
Agenda Sessions
Advancing RNA Therapeutics: Preclinical Translation of Antibody Oligonucleotide Conjugates (AOC)
, 2:15pmView Session
